Skip to content
The Nexus
DossierENTITY

Jeremy Levin

Coverage of Jeremy Levin in the Nexus archive.

Earliest in view: May 28 · 18:20 UTCMost recent: Jun 24 · 20:39 UTC
Co-mentioned in this coverage
Recent coverage
  • WORLDJun 24 · 20:39 UTCKYIV POST
    US State Department Says Ukraine Is Currently Winning the War

    Jeremy Levin, a senior US State Department official, stated in Gdansk that Ukraine is now winning the war by turning the situation around and seizing battlefield initiative. He noted Ukrainian forces are shifting to an offensive posture while Russian troops await winter, and highlighted strikes on Russian infrastructure. Washington may also tighten sanctions on Russian oil with EU partners.

  • HEALTHMay 28 · 18:48 UTCSTAT NEWS
    STAT+: Biotech veteran Jeremey Levin on why the industry’s future is secure, but American leadership is at risk

    Jeremy Levin, founder of Ovid Therapeutics and former CEO of Teva Pharmaceuticals, argues in his book that political upheaval, weakening institutions, and short-term investing threaten the biotech industry's future despite scientific advancements. He advocates for federal policy changes to support biotech investment and for pharmaceutical companies to address regulatory challenges.

  • HEALTHMay 28 · 18:20 UTCSTAT NEWS
    Biotech exec Jeremy Levin on the industry’s strategic turning point

    Jeremy Levin's new book 'Biotech in the Balance' addresses challenges facing the biotech industry and offers a roadmap for its future. The article also recaps recent biotech developments, including Eli Lilly's gene-editing treatment for high cholesterol and a longevity startup's funding.

Jeremy Levin · Dossier · The Nexus